Philpen Risk Assessment Form Revised 2022
Philpen Risk Assessment Form Revised 2022
I. PATIENT’S INFORMATION
Patient Name: (SURNAME, Given Name, Middle Name) Age Sex Birthdate:
Patient's Address:
Persons with Disability ID Card No., if applicable: Employment Status: [ ] Employed [ ] Unemployed [ ] Self-employed
[ ] IP [ ] Non-IP Ethnicity:
5.1 Tobacco Use [ ] Q1 Never Used (proceed to Q2) If YES to Q2-Q4, follow the tobacco cessation protocol
(5As) and use Form 1. Tobacco Cessation Referral
[ ] Q2 Exposure to secondhand smoke Protocol, if needed.
[ ] Q3 Former tobacco user (stopped smoking >1 year)
5.2 Alcohol Q1. [ ] Never Consumed [ ] Yes, drinks alcohol If NO, congratulate the patient. The patient is at a lower
Intake risk of drinking alcohol.
5.3 Physical Does the patient do at least 2.5 hours a week of moderate-intensity If NO or patient does not reach the recommended
Activity physical activity? hours/week off moderate-intensity physical activity, give
lifestyle modification advice following Annex 1. Healthy
[ ] Yes [ ] No Lifestyle Module.
5.4 Nutrition and Q1 Does the patient eat high fat, high salt food (processed/ fast food If YES to the question, give lifestyle modification advice
Dietary following Annex 2. Nutrition Practice Guidelines for Health
Assessment such as instant noodles, burgers, fries, dried fish), "ihaw-ihaw/fried Professionals in the Primary Care Screening
(e.g.
isaw, barbecue, liver, chicken skin) and high sugar food and drinks
(e.g.
5.7 Body Mass Index (wt.[kgs]/ht.[cm]/ht.[cm] x 10,000): 5.8 Waist Circumference (cm): F <80cm M<90
VLDL:
Triglyceride:
6.2 Chronic CHECK all applicable: If YES to any of the symptoms, obtain peak expiratory flow rate
Respiratory Diseases (PEFR). Give inhaled salbutamol, then repeat after 15 minutes.
(Asthma and COPD)
[ ] Breathlessness (or a "need for air")
Result:
[ ] Chronic cough
[ ] >20% change from baseline (consider Probable Asthma)
[ ] Sputum (mucous) production
[ ] <20% change from baseline (consider Probable COPD)
[ ] Chest tightness*
[ ] Wheezing*
VII. MANAGEMENT
Medications:
a. Anti-Hypertensives [ ] Yes [ ] No
b. Oral Hypoglycemic Agents/Insulin [ ] Yes [ ] No
Date of Follow-up:
Remarks: